First Quadrant’s Opko Health OPK Stock Holding History

First Quadrant’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,400	Closed	-$98K	–	842
2016 Q1	$98K	Hold	9,400	–	–	﹤0.01%	645
2015 Q4	$94K	Hold	9,400	–	–	﹤0.01%	618
2015 Q3	$79K	Buy	+9,400	New	+$124K	﹤0.01%	632

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Quadrant's OPK Position: Q2 2016 in Review

First Quadrant sold out of Opko Health (OPK) in Q2 2016, closing a stake of 9,400 shares — an estimated $98K sold.

First Quadrant first reported a position in OPK in Q3 2015 and held it in 3 quarters. The position peaked at $98K in Q1 2016. 245 funds tracked by Wall St. Rank hold OPK as of Q2 2016.

First Quadrant reported no remaining Opko Health position as of Q2 2016 after selling out during the quarter.
First Quadrant sold 9,400 Opko Health shares in Q2 2016, an estimated $98K.
First Quadrant first reported a position in Opko Health in Q3 2015 and held it in 3 quarters.
First Quadrant's Opko Health position peaked at $98K in Q1 2016.
245 funds tracked by Wall St. Rank held Opko Health as of Q2 2016.

Based on First Quadrant's 13F filing for Q2 2016, filed 19 Jul 2016.